Related Experiment Videos
Uridine potentiates haloperidol's disruption of conditioned avoidance responding
C S Myers1, H Fisher, G C Wagner
1Department of Psychology, Rutgers University, New Brunswick, NJ 08903.
Brain Research
|July 18, 1994
Summary
Uridine supplementation may enhance antipsychotic medication efficacy. Co-administering uridine with haloperidol amplified the drug
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Uridine, a pyrimidine nucleoside, has shown potential in psychosis treatment by modulating dopamine release.
- Haloperidol, a typical neuroleptic, is used to treat psychosis but can cause side effects.
Purpose of the Study:
- To investigate the effects of uridine co-administered with haloperidol on conditioned avoidance responding in rats.
- To determine if uridine enhances the antipsychotic effects of haloperidol and potentially reduces required dosages.
Main Methods:
- Rats were administered uridine (32 mg/kg, i.p.) and varying doses of haloperidol (0.05–0.4 mg/kg, i.p.).
- One-way conditioned avoidance responding was assessed to measure behavioral effects.
- Effects were evaluated after acute and chronic (27 days) uridine treatment.
Main Results:
- Haloperidol dose-dependently impaired avoidance behavior and increased latencies.
- Uridine potentiated haloperidol's disruptive effects on avoidance and avoidance latency.
- Uridine did not potentiate the increase in escape latency induced by haloperidol.
Conclusions:
- Uridine coadministration may enhance the antipsychotic efficacy of traditional neuroleptics like haloperidol.
- This potentiation suggests a potential strategy to reduce neuroleptic dosage and associated side effects.